Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON48705
NL-OMON48705
Completed
Not Applicable

Cefazolin plasma levels and pharmacokinetic parameters during adult cardiac surgery: after implementation of a new protocol for antibiotic prophylaxis. - CefCheck

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
40
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Informed consent
  • •Age \>18 year
  • •Cardiac surgery with the use of CPB
  • •Use of cefazolin as antibiotic prophylaxis

Exclusion Criteria

  • •No informed consent
  • •Age \<18 years
  • •Cardiac surgery without use of CPB
  • •Known allergy to cefazolin
  • •Active infection treated with antibiotics before surgery
  • •Kidney function impairment, defined as eGFR \<35 ml/min
  • •Liver function impairment, defined as ASAT or ALAT \>3 times normal values.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Plasma pharmakocinetics of prophylactic Cefazolin administration for cardiac surgery: comparison of cardiopulmonary bypass priming with additive human Albumin 20% vs pure crystalloid priming
EUCTR2020-002756-21-ATDepartment of Cardiothoracic Anesthesia and Intensive Care Medicine, Medical University of Vienna40
Completed
Phase 4
Cefazolin Pharmacokinetics: Elimination Clearance in NeonatesProphylaxis
NCT01295606Universitaire Ziekenhuizen KU Leuven40
Completed
Not Applicable
Surgical Site Infection StudyCava-pulmonary Anastomosis
NCT01449669Children's Hospital of Philadelphia14
Recruiting
Phase 1
Pharmacokinetics study of Cefazolin in haemodialysisChronic haemodialysis patients suffering from infection.MedDRA version: 21.0Level: LLTClassification code: 10007810Term: Catheter related infection Class: 10021881MedDRA version: 21.1Level: LLTClassification code: 10066622Term: Chronic hemodialysis Class: 10042613Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
CTIS2023-506734-73-00Centre Hospitalier Regional Universitaire De Tours50
Completed
Not Applicable
Determination of perioperative levels of cefazolin in paediatric cardiac surgical patientsCongenital heart disease
ACTRN12618001183279Queensland Paediatric Cardiac Services60